Phibro Animal Health Corp (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, November 6th, Wall Street Journal reports. Stockholders of record on Wednesday, November 28th will be paid a dividend of 0.12 per share on Wednesday, December 19th. This represents a $0.48 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Tuesday, November 27th. This is a positive change from Phibro Animal Health’s previous quarterly dividend of $0.10.
Phibro Animal Health has increased its dividend payment by an average of 26.0% per year over the last three years. Phibro Animal Health has a payout ratio of 26.7% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $1.77 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 27.1%.
Shares of NASDAQ:PAHC opened at $33.64 on Monday. The stock has a market capitalization of $1.36 billion, a PE ratio of 19.33, a PEG ratio of 2.88 and a beta of 0.82. The company has a current ratio of 3.26, a quick ratio of 1.82 and a debt-to-equity ratio of 1.62. Phibro Animal Health has a fifty-two week low of $32.05 and a fifty-two week high of $54.62.
In other Phibro Animal Health news, VP Daniel M. Bendheim sold 2,500 shares of Phibro Animal Health stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the completion of the transaction, the vice president now owns 2,500 shares in the company, valued at $110,750. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $42.84, for a total transaction of $428,400.00. Following the transaction, the insider now owns 10,000 shares of the company’s stock, valued at approximately $428,400. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,020 shares of company stock valued at $1,978,371. 50.29% of the stock is currently owned by company insiders.
PAHC has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 price objective for the company in a research note on Thursday, August 30th. BidaskClub upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, August 8th. ValuEngine cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Monday, November 12th. Finally, Morgan Stanley raised their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the company an “underweight” rating in a research note on Wednesday, August 29th. Three investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $43.50.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Read More: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.